Journal article
Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis
Abstract
BACKGROUND AND OBJECTIVES: A safety signal regarding cases of AKI after exposure to serotonin-norepinephrine reuptake inhibitors (SNRIs) was identified by Health Canada. Therefore, this study assessed whether the use of SNRIs increases the risk of AKI compared with selective serotonin reuptake inhibitors (SSRIs) and examined the risk associated with each individual SNRI.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Multiple retrospective …
Authors
Renoux C; Lix LM; Patenaude V; Bresee LC; Paterson JM; Lafrance J-P; Tamim H; Mahmud SM; Alsabbagh MW; Hemmelgarn B
Journal
Clinical Journal of the American Society of Nephrology, Vol. 10, No. 10, pp. 1716–1722
Publisher
Wolters Kluwer
Publication Date
October 2015
DOI
10.2215/cjn.11271114
ISSN
1555-9041
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Acute Kidney InjuryAdolescentAdultAgedCanadaCase-Control StudiesChildDatabases, FactualDesvenlafaxine SuccinateDuloxetine HydrochlorideFemaleHumansIncidenceMaleMiddle AgedRisk AssessmentSelective Serotonin Reuptake InhibitorsSerotonin and Noradrenaline Reuptake InhibitorsUnited KingdomUnited StatesVenlafaxine HydrochlorideYoung Adult